Cardiac Amyloidosis Imaging
Research activity is centred on cardiac amyloidosis, with a focus on imaging-based diagnosis and the evaluation of PET techniques for identifying disease involvement in the heart.
- [18F]florbetaben PET
- Cardiac amyloidosis diagnosis
- Visual image assessment
The sponsor’s clinical interest extends to distinguishing amyloid-related cardiac disease from standard clinical findings in a setting involving multiple collaborating research sites across Europe.
AL Amyloidosis
Clinical research also covers AL amyloidosis, reflecting interest in systemic amyloid disorders and their cardiac manifestations.
- Light-chain amyloidosis
- Systemic amyloid disease
- Cardiac involvement
This area aligns with efforts to improve recognition of amyloid subtypes that can affect cardiovascular function and complicate diagnosis.
ATTR Amyloidosis
Another area of interest is ATTR amyloidosis, supporting research into transthyretin-related amyloid disease and its overlap with cardiac presentations.
- Transthyretin amyloidosis
- Amyloid subtype differentiation
- Heart-related amyloid disease
The sponsor’s trial portfolio includes conditions that require careful separation of amyloid subtypes in clinical evaluation.
Molecular Imaging in Rare Disease Diagnosis
The sponsor is involved in molecular imaging approaches for rare disease diagnosis, with emphasis on image interpretation in amyloid-related disorders.
- Diagnostic imaging
- Radiotracer-based assessment
- Specialist clinical evaluation
Its research activity is organised through a clinical trial information desk in Berlin, with active studies conducted across Germany and another country in Europe.
